Showing 10 Clinical Trials

Ravulizumab for COVID-19

This study intends to evaluate the safety and efficacy of ravulizumab for the treatment of COVID-19 severe pneumonia, acute lung injury or acute respiratory distress syndrome (ARDS).

P2 BMT vs. SOC in SCD (CTN1503)

The purpose of this clinical trial is to find out if bone marrow transplantation is better than standard of care in improving survival and decreasing sickle cell-related complications for young adults with severe sickle cell disease (SCD).

CN41144 OCARINA

This research study will evaluate the pharmacokinetics (what the body does to the drug), safety and tolerability, of a drug (ocrelizumab) administered subcutaneously (under the skin) to patients with Multiple sclerosis (MS).

Biomarkers in Healthy Controls

The goal of the study is to learn more about the amounts of certain substances in the blood of healthy individuals of different ages, weights, and genders. This information will be compared to data from patients with multiple sclerosis.

Web-based Automated Imaging Differentiation of Parkinsonism (wAID-P Study)

The purpose of this study is to test the performance of a web-based software tool called Automated Imaging Differentiation of Parkinsonism (wAID-P).

ASEM and AZAN PET in SCZ

The purpose of this research study is to learn more about the chemistry of the brain of people with schizophrenia and healthy controls.

ECDM2

The purpose of this research study is to better understand memory, thinking, motivation, and how they impact daily life and functioning.

Long COVID Study

The purpose of this research study is to determine whether fluvoxamine reduces the symptoms of long COVID.

Community-Associated Drug-Resistant Microbes Study

The purpose of this study is to learn more about drug-resistant microbes in the community (including how often people have them, who is most likely to have them, and places in the home where they may be present).

PEP

This study will look at how mood, hormones, and brain response to peers change over adolescence.